Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Loading...
Community
/
United Kingdom
/
Food, Beverage & Tobacco
/
Tate & Lyle
Create a narrative
Tate & Lyle Community
LSE:TATE Community
3
Narratives
written by author
0
Comments
on narratives written by author
41
Fair Values set
on narratives written by author
Community Investing Ideas
Tate & Lyle
Popular
Undervalued
Overvalued
Tate & Lyle
AN
AnalystConsensusTarget
Based on Analyst Price Targets
Integrating CP Kelco And Partnering With Manus Will Drive Growth And Enhance Profitability
Key Takeaways Expansion through CP Kelco enhances specialty solutions, driving revenue growth and improving profitability via anticipated cost synergies and EBITDA margin uplift. Strong cash flow and disciplined financial management fuel share buybacks, increasing EPS, while innovation drives new revenue streams and strengthens market position.
View narrative
UK£7.09
FV
35.5% undervalued
intrinsic discount
10.05%
Revenue growth p.a.
Set Fair Value
2
users have liked this narrative
0
users have commented on this narrative
30
users have followed this narrative
9 days ago
author updated this narrative
Tate & Lyle
AN
AnalystLowTarget
Community Contributor
Regulatory And Integration Hurdles Will Constrain Upside But Spur Revaluation
Key Takeaways Integration challenges, rising compliance costs, and volatile supply chains may delay expected growth and put sustained pressure on margins and earnings momentum. Slower innovation uptake, regulatory risks, and uneven global demand could constrain revenue acceleration and postpone stronger company valuation.
View narrative
UK£5.9
FV
22.5% undervalued
intrinsic discount
9.96%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
16 days ago
author updated this narrative
Tate & Lyle
AN
AnalystHighTarget
Community Contributor
Rising Health Trends And Urbanization Will Expand Specialty Markets
Key Takeaways Synergy gains, innovation-driven specialty revenue growth, and superior solution-selling could significantly boost margins, operating leverage, and earnings beyond current expectations. Expansion in emerging markets and rising global demand for healthier food ingredients position Tate & Lyle for long-term revenue gains and increased pricing power.
View narrative
UK£8.2
FV
44.2% undervalued
intrinsic discount
12.44%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
16 days ago
author updated this narrative